Why the study?
Patients with mechanical heart valves face increased thromboembolic risk, and it was unclear whether low molecular weight heparin or unfractionated heparin is the more beneficial bridging anticoagulation strategy.
Does LMWH reduce thromboembolic events and major bleeding compared to UFH in patients with mechanical heart valves requiring bridging anticoagulation?
Population
1366 events across 6 publications in patients with MHV
Comparison
LMWH vs UFH bridging anticoagulation
Design
Meta-analysis of randomized controlled trials and observational studies
Authors
Loading...
LMWH may be safer and more effective than UFH for bridging in MHV; leaves open need for confirmatory RCTs.
Does LMWH reduce thromboembolic events and major bleeding compared to UFH in patients with mechanical heart valves requiring bridging anticoagulation?
LMWH provides a safer and more effective bridging anticoagulation strategy than UFH in patients with mechanical heart valves, significantly reducing thromboembolic risk without increasing major bleeding.
Tao et al. (2020) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: